IDMED launches new generation TOFscan at Euroanaesthesia 2026
Partnering with Dräger, the device aims to improve neuromuscular blockade monitoring in clinical practice.
See the latest news and media coverage for IDMED. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of medical devices for analgesia, neuromuscular blockade, and pupillometry
idmed.frLast updated
In short: IDMED launched its next-generation TOFscan monitor and expanded its global presence through clinical partnerships and professional congresses.
Partnering with Dräger, the device aims to improve neuromuscular blockade monitoring in clinical practice.
The development aims to broaden possibilities of the NeuroLight pupillometer and will be first shown at the June congress.
Quantitative Pupillary index is evaluated and validated as a prognostic tool in a multicentre prospective study on cardiac arrest patients.
These are the first to explicitly recommend quantitative neuromuscular monitoring before tracheal intubation. This milestone underscores its essential role across the entire anaesthetic pathway.
Located in Marseille, this company develops different technologies for operating rooms, its flagship product allowing to measure the pain of a sleeping patient thanks to the...
IDMed, located at the Technopôle de Château Gombert in Marseille and housed within the Technoptic hotel of Marseille Innovation, develops and markets systems...
After fifteen years spent filming the eye for an optics company, Thierry Bagnol and Frédéric Bernert have acquired the certainty that one can...
Medical The Marseille-based company, which has developed a portable pupillometer intended to help anesthesiologists perfect their dosage, enters the commercialization phase. ...
Track IDMED and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to IDMED and other trending companies.